It has recently been shown that several members of the tetraspan superfamily, including CD9 and CD63, associate with each other and with ␤ 1 integrins. In this study, we examined the distribution of a recently identified tetraspan, PETA-3 (CD151), and of CD9, CD63, ␣ 5 ␤ 1, and the integrin ␤ 1 chain in normal human tissues by the indirect immunoperoxidase and alkaline phosphatase-anti-alkaline phosphatase techniques. PETA-3 showed a broad distribution and was expressed by endothelium, epithelium, Schwann cells, and dendritic cells and by skeletal, smooth, and cardiac muscle. Expression in skin was mostly restricted to the basal cells of the epidermis and was downregulated on differentiation. In the small intestine, PETA-3 was expressed by crypt and villous enterocytes with a mostly basolateral distribution, but was not detectable on the brush border. CD9 was expressed on the plasma membrane of enterocytes in crypts and at the bases of the villi whereas CD63 demonstrated a unique granular appearance concentrated in the apical cytoplasm below the brush border. The findings of this study show co-localization of PETA-3 with CD9, CD63, ␣ 5 ␤ 1, and ␤ 1 in particular tissues, demonstrating that tetraspan/integrin complexes may occur. However, the lack of co-localization of these antigens in other tissues also implies distinct roles for these molecules. ( J Histochem Cytochem 45:515-525, 1997 ) Although the biochemical functions of the TM4SF are unknown, several studies using monoclonal anti-Correspondence to:
R ecently , a cDNA clone encoding a 27-kD protein PETA-3 (platelet endothelial tetraspan antigen-3) was isolated from a library constructed from the megakaryoblastic cell line MO7e (Fitter et al. 1995) . The clone encoded an open reading frame of 253 amino acids and sequence comparisons revealed 25-30% amino acid identity with several members of the recently described transmembrane 4 superfamily (TM4SF), also known as tetraspans. Subsequently, PETA-3 was independently cloned from the adult T-cell leukemia cell line SF-HT by Hasegawa et al. (1996) and was named SFA-1 (SF-HT-activated gene 1). PETA-3, or SFA-1, expression was shown to be upregulated after transformation of SF-HT cells by human T-cell leukemia virus Type 1. PETA-3 was assigned CD151 at the VIth International Leucocyte Differentiation Antigen workshop (Ashman et al. in press) .
Members of the TM4SF are characterized by four highly conserved hydrophobic regions that are believed to be membrane-spanning which show little homology with other proteins containing four transmembrane domains (Wright and Tomlinson 1994; Horejsi and Vlcek 1991) . Also characteristic of tetraspan proteins is the presence of a large divergent extracellular loop between the third and fourth membrane-spanning domains, which has been suggested to define the functional specificity of the particular tetraspan. Members of the TM4SF have been identified in a diverse range of organisms, including Schistosoma (Wright et al. 1990) , Drosophila (Kopczynski et al. 1996) , and humans (Wright and Tomlinson 1994) . This evolutionary conservation of tetraspans suggests an integral role for these molecules in cell biology. bodies (MAbs) have shown tetraspans to mediate a broad range of biological responses. Anti-CD9 and anti-PETA-3 MAbs are able to induce platelet activation and mediator release by crosslinking of Fc ␥ RII, the low-affinity IgG receptor (Roberts et al. 1995; Ashman et al. 1991; Worthington et al. 1990 ). More recent studies in platelets have demonstrated intrinsic signaling capacity for CD9, with anti-CD9 F(ab Ј ) 2 fragments inducing phosphorylation of the tyrosine kinase syk (Ozaki et al. 1995) . Signal transduction events have also been demonstrated in B-cells, granulocytes, and monocytes by anti-CD53 MAbs (Olweus et al. 1993) . MAbs against CD9 and CD81 can cause homotypic adhesion of pre-B-cells (Masellis-Smith et al. 1990; Takahashi et al. 1990 ). Increased adhesion of neutrophils to endothelium (Forsyth 1991) and adhesion of pre-B-cells to bone marrow fibroblasts through the modulation of fibronectin receptors has also been demonstrated for anti-CD9 MAbs (Masellis-Smith and Shaw 1994) . A potential role for tetraspans in modulating adhesion events has been further supported by the finding that several members are associated with integrin complexes. Initially, CD9 was demonstrated to associate with the ␣ IIb/ ␤ 3 complex in platelets (Slupsky et al. 1989) , and subsequent studies have highlighted associations with integrins of the ␤ 1 subfamily. For example, immunoprecipitation studies have shown CD9 to be associated with both ␣ 4 ␤ 1 and ␣ 5 ␤ 1 in the pre-B-cell line NALM-6, whereas in the erythroleukemia-derived cell line HEL, CD9 was associated only with ␣ 4 ␤ 1 (Rubinstein et al. 1994 ). CD63 has been demonstrated to associate with ␣ 3 ␤ 1 and ␣ 6 ␤ 1 integrins in HT1080 fibrosarcoma cells and in transfected K562 cells expressing either the ␣ 3 or ␣ 6 chain (Berditchevski et al. 1995) . Furthermore, CD9, CD63, and CD81 were demonstrated to associate with each other and ␣ 3 ␤ 1 to form tetraspan/integrin and tetraspan/tetraspan/integrin complexes (Berditchevski et al. 1996) . Similarly, PETA-3 has recently been shown to associate with ␣ 5 ␤ 1, and CD63 in MO7e and HEL cells (S. Fitter, unpublished data) and CD9 and the integrin ␤ 1 chain in platelets (P. Sincock, unpublished data). The physical association of several tetraspan members with integrins suggests a possible role for tetraspans in modulation of integrin function.
Previous studies using MAb 14A2.H1 have shown expression of PETA-3 on platelets, endothelium, some myeloid leukemia cells, and epithelium of tonsil sections (Ashman et al. 1991) . Furthermore, studies of PETA-3 mRNA distribution by Northern blotting analysis showed mRNA expression in all tissue homogenates examined, with the exception of brain (Fitter et al. 1995) . Because PETA-3 is expressed by endothelium, it was unclear whether or not the vasculature component of the tissues examined accounted for their positivity by Northern analysis. Furthermore, the association of PETA-3 with ␣ 5 ␤ 1, CD9, and CD63 by biochemical studies suggests that these antigens may be co-expressed with PETA-3 in particular tissues. This study investigated the tissue localization of the newly described PETA-3 and the possibility that it is co-localized with CD9, CD63, ␣ 5 ␤ 1, and ␤ 1 chain in normal human tissues.
Materials and Methods

Tissues
Normal adult human tissue specimens were obtained with approval from the Royal Adelaide Hospital Ethics Committee. Tonsil and gut were obtained through surgical procedures and embedded within 1 h. Postmortem tissues, including brain, skeletal muscle, cardiac muscle, skin, kidney, liver, lung, pancreas, spleen, thyroid, and adrenal gland, were obtained within 6 hr of death. Solid tissues were placed in Tissue-Tek OCT compound (Miles; Elkhart, IN) and frozen by immersion into isopentane precooled in liquid nitrogen. Skeletal and cardiac muscle were not embedded in OCT but were plunged directly into liquid nitrogen and stored at Ϫ 70C. Fresh frozen air-dried sections (5 m) were fixed in 95% ethanol for 10 min at 4C and washed with three changes of cold (4C) PBS before staining by the indirect immunoperoxidase technique. Peripheral blood was collected in heparin and bone marrow mononuclear cells (BMMNCs) were obtained and Ficoll-purified as previously described (Simmons et al. 1994 ). Blood and cytocentrifuge slides were allowed to air-dry and were stored at Ϫ 70C before staining with the alkaline phosphatase-anti-alkaline phosphatase (APAAP) technique.
Monoclonal Antibodies
The anti-PETA-3 MAb 11B1.G4 (IgG 2a ) was raised by fusion of splenocytes from Balb/c mice immunized with MO7e megakaryoblastic leukemia cells with the X-63.Ag8.653 myeloma cell line. The resultant hybridoma supernatants were screened on FDCP1 cells transfected with PETA-3 cDNA (Fitter et al. 1995) . Anti-CD9 MAb 1AA2.H9 (IgG 1 ) (Cole et al. 1989 ) and anti-CD63 MAb 12F12.1G2 (IgG 1 ) (Zannettino et al. 1996) were raised as described. The MAb 61.2C4 (IgG 1 ) against the ␤ 1 integrin chain (unpublished) was a kind gift from Dr. J. Gamble (Hanson Centre for Cancer Research) and the anti-␣ 5 ␤ 1 MAb PHM2 (IgG 1 ) (Hancock et al. 1983; Becker et al. 1981 ) was kindly supplied by Dr. Randall Faul (Renal Unit, Royal Adelaide Hospital). Isotype-matched negative control MAbs 1B5 (IgG 1 ), anti-Giardia (G. Mayrhofer, unpublished) and Sal-1 (IgG 2a ), anti-Salmonella (O'Connor and Ashman 1982) were also included in all experiments.
Immunohistochemistry
All solid tissues were examined by the indirect immunoperoxidase technique, and peripheral blood smears and bone marrow aspirates were examined by the APAAP technique. To block Fc-mediated binding, MAb culture supernatant was supplemented with 10% heat-inactivated normal rabbit serum before application to sections. For indirect immuno-peroxidase staining, sections were allowed to incubate for 1 hr at 4C with MAb. After washing in three changes of cold PBS, sheep anti-mouse immunoglobulin (Ig)-peroxidase (Amersham; Poole, UK) diluted 1:20 in 10% NRS was applied and incubated for 1 hr at 4C. After further washes, sections were brought to room temperature and peroxidase activity was detected by incubation with 1.3 mM 3,3 Ј -diaminobenzidine tetrahydrochloride (Sigma; St Louis, MO) containing 0.07% hydrogen peroxide (Sigma). Sections were then washed in PBS, counterstained with Mayer's hematoxylin, dehydrated through alcohol and safsolvent (Ajax Chemicals, Australia) gradients, and mounted with Depex (BDH Gurr; Sydney, Australia). APAAP staining was performed as previously described (Ashman et al. 1991) , with the exception that cells were fixed with methanol.
Results
All tissues were examined for expression of PETA-3 using MAb 11B1.G4 in the indirect immunoperoxidase assay. Adjacent sections were stained with MAbs against CD9 (1AA2.H9), CD63 (12F12.1G2), the ␤ 1 integrin family (anti-␤ 1 MAb 61.2C4), and the ␣ 5 ␤ 1 integrin (PHM2). The findings are summarized in Table 1. Isotype-matched negative control MAbs were included in all experiments as specificity controls. Apart from the endogenous peroxidases of eosinophils, alveolar macrophages, and Kupffer cells, no other cells in any of the tissues stained with these MAbs by the indirect immunoperoxidase technique. One exception was tonsillar follicular dendritic cells, which showed low levels of binding of the IgG 2a control Sal-1. No staining of peripheral blood/bone marrow cells was seen with negative control MAbs by the APAAP technique.
Tissue Distribution of PETA-3, CD9, CD63, ␣ 5 ␤ 1, and the Integrin ␤ 1 Subfamily Vascular endothelium was stained strongly with MAbs against PETA-3, CD9, and ␤ 1. Perivascular smooth muscle and several connective tissue components were also positive. A similar distribution was seen for ␣ 5 ␤ 1. However, the degree of staining was much weaker and connective tissue components failed to react. CD63 was identified on endothelium and connective tissue components, but was not detected on smooth muscle. The following descriptions are of PETA-3, CD9, CD63, ␣5␤1, and ␤1 integrin localization within the tissues examined. The results obtained are summarized in Table 1 .
Skin. PETA-3 was expressed on the cell membrane of the basal keratinocytes. Expression was strongest on the membrane adjacent to the basal lamina ( Figure  1A) . The ␤1 integrin chain was also highly expressed on the membrane of basal keratinocytes ( Figure 1B) . In contrast, ␣5␤1 integrin was expressed at low levels by keratinocytes throughout the epidermis ( Figure  1C ). Anti-CD9 MAb produced intense staining of all keratinocytes ( Figure 1D ) and, in further contrast to PETA-3, did not stain the cell membrane of basal keratinocytes that contacts the basal membrane. Anti-CD63 stained keratinocytes very weakly, although melanocytes stained strongly, as has been previously described (Hotta et al. 1988 ).
Small Intestine. PETA-3 was expressed on the basolateral membranes of the columnar epithelial cells of the villi ( Figure 1E ) and crypts. Smooth muscle cells within villi and the muscularis mucosa were also positive for PETA-3. ␤1 integrins were present on the basolateral membranes of epithelium in crypts and on the villi. However, the anti-␤1 MAb also diffusely stained the basal cytoplasm ( Figure 1F ). Smooth muscle cells within villi and the muscularis mucosa were also strongly positive for ␤1 integrin. CD9 ( Figure 1G ) was expressed on the basolateral membrane of immature enterocytes in the crypts and on the bases of the villi. The anti-CD9 MAb also stained smooth muscle. CD63 was also detected on crypt and villous epithelium but, in contrast to PETA-3 and CD9, CD63 had a granular appearance and was localized to the apical cytoplasm below the brush border ( Figure 1H ). ␣5␤1 integrin was detected only on smooth muscle fibers within the villi ( Figure 1I ) and the muscularis mucosa. Staining of some intraepithelial lymphocytes (IELs) with MAbs against CD9, CD63, and ␤1 integrin was also observed.
Connective Tissue. Within the dense connective tissue of the deep dermis, fibroblasts were stained by MAbs to CD9, CD63, and the ␤1 integrin chain. PETA-3 and ␣5␤1 were not detected on fibroblasts. In the superficial dermis, cells with irregular processes were stained strongly by anti-CD63 MAb and at lower levels by MAb against PETA-3, CD9, and ␤1. No detectable staining of these cells was seen with anti-␣5␤1. Although these cells may be macrophages and/ or mast cells, other histochemical techniques would be required to confirm their identity.
Lung. Within the lung parenchyma, smooth muscle associated with bronchi, bronchioles, and blood vessels, epithelium, and alveolar pneumocytes were stained strongly by MAb against PETA-3, CD9, and the ␤1 integrin chain. ␣5␤1 was also present on these cell types, although staining was less intense. CD63 was present on pneumocytes and airway epithelium, but staining was less intense than with the other MAbs. Endothelial cells of alveolar capillaries and larger blood vessels were stained by all MAbs tested. Alveolar macrophages showed some staining with negative control MAbs. Therefore, the specificity of staining of these cells could not be determined.
Kidney. Strong staining with MAb against PETA-3
and ␤1 integrin was seen on periarteriolar smooth muscle and endothelial cells of blood vessels and glomeruli (Figures 2A and 2B) . Staining was weaker for CD9, CD63 and ␣5␤1 on glomerular endothelium. Epithelium of the proximal and distal convoluted tubules was stained weakly with MAbs against ␤1 integrin, PETA-3, and CD63. Very weak staining of these tubules was observed with anti-CD9, and no detectable staining was seen with anti-␣5␤1. In contrast to the staining observed with other tetraspan MAbs, anti-CD9 strongly stained epithelial cells of collecting ducts. The ␤1 integrin chain was also strongly stained on collecting ducts, but no staining of ␣5␤1 was detected.
Liver. Endothelium in hepatic sinusoids stained strongly positive for PETA-3 ( Figure 2C) , CD63, and ␤1 integrin chain, whereas staining for CD9 and ␣5␤1 was much weaker. Columnar epithelium of intrahepatic bile ducts was stained with all MAbs examined. The cell membranes of hepatocytes also showed weak staining by MAbs against PETA-3, CD9, and the ␤1 integrin chain. Kupffer cells showed weak staining with negative control MAbs. Therefore, the specificity of staining of these cells could not be determined.
Pancreas. Acinar cells and pancreatic islets were either unstained or lightly stained for most MAbs tested. However anti-CD63 staining of these cells was very strong. The columnar epithelium of intralobular excretory ducts showed diffuse staining by MAbs against PETA-3, CD63, the ␤1 integrin chain, and ␣5␤1, but CD9 was not detected.
Cerebral Cortex. Vascular endothelium was positive for PETA-3 ( Figure 2D ), CD63, ␣5␤1, and ␤1. Nerve bodies in the gray matter and myelinated fibers in the white matter were not stained. Anti-CD9 MAb also stained endothelium and, in addition, the white matter showed strong diffuse staining of the neuropil, as previously described (Rossler et al. 1992) .
Spleen. Within adult spleen, lymphocytes in the white pulp were unstained by all MAbs. Low-level staining was seen with anti-PETA-3, CD9, CD63, and ␤1 MAbs in the region of periarteriolar lymphoid sheaths and white pulp, which may have been staining of interdigitating cells. Central arterioles were stained strongly by anti-␤1 MAb and less strongly by MAbs against PETA-3 ( Figure 2E) , CD9, and ␣5␤1. Staining of central arterioles by anti-CD63 was barely detectable. Red pulp sinusoids and splenic cords were also stained by MAbs against PETA-3, CD9, CD63, ␣5␤1, and the ␤1 chain.
Tonsil. Squamous epithelium, germinal centers, and high endothelial venules (HEVs) were stained by all MAbs tested. As in skin, expression of PETA-3 and ␤1 by epithelial cells was restricted to the basal layer, whereas strong staining for CD9 was observed on cell membranes throughout the epithelium. Staining of CD63 and ␣5␤1 was weak and showed a similar distribution to that of CD9. Lymphocytes within both Tand B-cell zones were not stained by any of the MAbs tested. HEVs were stained moderately by anti-CD63 and were strongly positive for PETA-3 ( Figure 2F ), CD9, ␣5␤1, and the integrin ␤1 chain. Follicular dendritic cells within germinal centers were stained by all MAbs tested. Staining was weak for ␣5␤1 and CD63 and was stronger for PETA-3 ( Figures 2G and 2H) , CD9, and the ␤1 integrin chain. Although some staining was seen with the IgG 2a negative control Sal-1, the staining by anti-PETA-3 MAb 11B1.G4 (IgG 2a ) was much stronger, and the IgG 1 anti-PETA-3 MAb 14A2.H1 also stained tonsillar follicular dendritic cells (data not shown), thus verifying the specificity of staining for these cells.
Peripheral Blood. PETA-3 staining was restricted to platelets only. MAbs against CD9, CD63, ␤1, and ␣5␤1 also stained platelets. Several other hemopoietic cell types, including neutrophils, macrophages, and monocytes (see Table 1 ), were also stained by these MAbs as has been previously described (reviewed in Barclay et al. 1993) .
Bone Marrow Mononuclear Cells. PETA-3 expression
was mostly restricted to cells of the megakaryocytic lineage, which stained very strongly ( Figure 2I ). Immature cells of the neutrophil lineage showed weak staining. Infrequent small cells were also weakly stained, and further studies would be required to determine their nature. All of the other MAbs tested stained cells of the megakaryocytic lineage as well as many other cell types, as reviewed in Barclay et al. (1993) .
Peripheral Nerve and Skeletal Muscle. Peripheral nerve fibers were identified within transverse sections of skeletal muscle. The perineurium of peripheral nerve fascicles was strongly positive for PETA-3 ( Figure  3A) , CD9, and ␤1 integrins, and was weakly positive for CD63 and ␣5␤1. Staining with isotype-matched negative control MAb is shown in Figure 3B . The myelin sheaths and cell bodies around the nuclei of Schwann cells were strongly positive for MAbs against PETA-3 and CD9 and also showed lower levels of staining for CD63 and the ␤1 integrin chain. Transverse sections of skeletal muscle showed that PETA-3 ( Figure 3A) , CD9, CD63, and ␤1 integrin were expressed on the sarcolemma of striated muscle cells. ␣5␤1 was not detected on skeletal muscle cells.
Heart. Cardiac muscle showed staining for PETA-3 ( Figure 4A ) and ␤1 integrin ( Figure 4B ) on the sarcolemma of muscle cells and capillary endothelium. Some diffuse cytoplasmic staining of cardiac muscle cells was also seen with these MAbs. Anti-CD63 and ␣5␤1 staining was much lower on cardiac muscle cells, and CD9 ( Figure 4C ) was restricted to the endothelium of blood vessels. Absence of staining in cardiac tissue with isotype matched negative control MAb is shown in Figure 4D .
Adrenal Cortex. Parenchymal cells of the zona glomerulosa and spongiocytes within the zona fasciculata were stained by anti-CD63 and ␤1 MAbs. PETA-3 and CD9 were also expressed by these cells. In each case, the MAbs stained the cell membranes and the periphery of cytoplasmic lipid droplets. Cells within the zona reticularis were also stained by these MAbs, although the pattern of staining on these cells was diffuse and cytoplasmic. Anti-CD63 stained spongiocytes strongly and cells of the zona reticularis very strongly. ␣5␤1 expression was not detected on parenchymal cells in any of the zones of the adrenal cortex.
Thyroid. The follicular epithelium and parafollicular cells were stained by MAbs against PETA-3, CD9, and CD63. Anti-PETA-3 and CD9 MAbs stained the cell membranes of follicular epithelial cells, whereas staining with CD63 showed a granular appearance. Follicular epithelium was not stained by anti-␤1 MAb, although ␤1 integrin was detected on the membrane of parafolicular cells with a distribution similar to that of PETA-3 and CD9. ␣5␤1 was not detected on follicular epithelium or parafolicular cells.
Discussion
The association of tetraspan molecules with each other and with ␤1 integrins has suggested a role for these proteins in the modulation of integrin function (Berditchevski et al. 1995 (Berditchevski et al. ,1996 Rubinstein et al. 1994 ). PETA-3, like other members of the TM4SF, appears to share these associations. Complexes containing PETA-3 in association with CD63 and ␣5␤1 in both MO7e and HEL cells (S. Fitter, unpublished data) have been shown. In addition, PETA-3 has been demonstrated to co-precipitate with CD9 and the integrin ␤1 chain from platelet lysates (P. Sincock, unpublished data). Although much emphasis has been placed on the characterization of these associations using cell lines, the distribution of PETA-3 in vivo and its colocalization with associated antigens in various tissues have not been studied in detail. Recently, it was shown that CD9, CD63, CD81, and ␣3␤1 co-localized in some cells in tissue sections of skin, breast, tonsil, and colon (Berditchevski et al. 1996) . Furthermore, coimmunoprecipitation experiments provided direct evidence demonstrating the existence of tetraspan/tetraspan/integrin complexes involving these molecules (Berditchevski et al. 1996) . Because PETA-3 has also been demonstrated to be involved in such complexes, the aim of our investigation was to determine the tissue distribution of PETA-3 and to compare systemati- cally the localization of known associated molecules, including CD9, CD63, and the ␣5␤1 integrin. PETA-3 was readily detected on vascular endothelium and smooth muscle in all tissues examined. Fibroblasts and some other undefined cells within connective tissues also expressed PETA-3, CD9, CD63, and ␤1 integrins, but ␣5␤1 was undetectable. The widespread expression of these antigens throughout connective tissue probably reflects their interaction with components of the extracellular matrix such as collagen, laminin, and fibronectin. Expression of PETA-3 by vascular endothelium was constant throughout all tissues examined, including regions of specialized endothelium (e.g., glomeruli, HEVs, hepatic sinusoids, alveolar capillaries, and capillaries constituting parts of the blood-brain barrier). The widespread expression of PETA-3 in endothelium suggests that its primary role may be in the maintenance of vascular integrity. This could be achieved through cooperation with integrins in modulating adhesion events with extracellular matrix, between endothelial cells, or with formed elements of blood. In addition, the widespread expression of PETA-3 suggests that endothelial activation by locally produced proinflammatory cytokines does not regulate the level of expression. Such regulation of expression was seen with CD63, a known marker of endothelial activation (Vischer and Wagner 1993) , which was not detected within central arteries of spleen yet was expressed within HEVs of the tonsil and most other vasculature. Interestingly, PETA-3 was expressed on the vasculature of brain tissue, although PETA-3 mRNA had not been previously detected by Northern analysis (Fitter et al. 1995) . CD63, ␣5␤1, and ␤1 were also restricted to the vasculature in brain tissue, whereas CD9 was expressed by other tissue components as well. Expression of CD9 in the brain parenchyma has been previously described (Rossler et al. 1992) , and results of the present study are similar. Interestingly, the restriction of the ␤1 integrin chain to the vasculature in brain suggests that CD9, unlike the other tetraspans, may be predominantly associated with another integrin ␤-chain or that it has an integrin-independent function in these cells.
Throughout most tissues in this study, the tetraspans investigated showed similar patterns of distribution. The co-localization of the tetraspan antigens with each other and with ␤1 integrins, in some cases ␣5␤1, is consistent with the concept that they can associate to form tetraspan/integrin or tetraspan/tetraspan/ integrin complexes. PETA-3 did co-localize with ␣5␤1 in several tissues examined, especially those that showed very high levels of PETA-3 expression. However, the stronger staining of ␤1 integrin throughout most tissues indicated the presence of other ␤1 integrins. Therefore, PETA-3 may associate with other ␤1 integrins in such cells.
PETA-3 was expressed at relatively high levels by cardiac muscle cells and was also expressed on striated skeletal muscle. The lack of co-localization of PETA-3 with ␣5␤1 in muscle cells again suggests that other ␤1 integrins may associate with PETA-3 in vivo. Because it has been demonstrated that CD9 associates with more than one ␤1 integrin, i.e., ␣4␤1 and ␣3␤1, it is possible that PETA-3 also associates with several ␤1 integrins.
PETA-3 expression was also observed in a number of epithelia. In the skin and tonsil, staining was restricted to the basal layers of the stratified epithelia and exhibited polarity, with brightest staining adjacent to the basal membrane. In contrast, CD9 was expressed by all keratinocytes in skin and showed an opposite polarity in cells of the stratum basale. The presence of PETA-3 close to the basement membrane suggests that it is involved in anchoring of cells to the basal lamina. The loss of PETA-3 by keratinocytes as they leave the proliferative compartment and lose contact with the basal lamina further supports this hypothesis. In contrast, CD9 may be primarily involved in interactions between keratinocytes, as suggested by its expression by keratinocytes throughout the epidermis and decreased expression on the basal membrane in cells of the stratum basale. ␤1 integrin expression was also restricted to the basal layers, suggesting that association with PETA-3 is involved in anchoring to the basement membrane.
Expression of PETA-3 by simple columnar or cuboid epithelia also demonstrated a basolateral distribution, especially in villous and crypt enterocytes of the small intestine. Whereas ␣5␤1 expression was not detected on these cells, the ␤1 integrin chain was present in a similar polarized distribution, again providing further evidence that PETA-3 may associate with other members of the ␤1 subfamily. The possibility of PETA-3 associations with other ␤1 integrins is presently being investigated. The basolateral distribution of PETA-3, CD9, and the ␤1 chain in epithelial cells implies that they may be involved in interactions of the cells with the basement membrane and possibly in intercellular adhesion. The expression of CD9 by gut epithelium was restricted to immature enterocytes of the crypts and the bases of the villi. Therefore, CD9 may be regulated during epithelial differentiation and its function may be limited to interactions with specific extracellular matrix components in the crypt microenvironment. In contrast to PETA-3 and CD9, CD63 expression was localized to granules or structures located in the apical cytoplasm, below the brush border. Ultrastructural studies would be necessary to determine whether CD63 is expressed on the brush border membrane. CD63 has been shown to possess a lysosomal targeting sequence (Metzelaar et al. 1991) and was demonstrated to localize in Weibel-Palade bodies of endo-thelial cells and platelet granules (Vischer and Wagner 1993; Nieuwenhuis et al. 1987) . The apical region of the enterocyte cytoplasm is rich in multivesicular bodies that express major histocompatibility complex (MHC) Class II proteins (Mayrhofer and Spargo 1990) . Therefore, CD63 may be expressed in the early endocytic pathway in enterocytes. Furthermore, other members of the TM4SF, CD37, CD53, CD81 (TAPA-1) and CD82 (R2/C3) have been shown to associate with MHC Class II molecules (Angelisova et al. 1994; Schick and Levy 1993) , suggesting that CD63 is also involved in these complexes.
Simple epithelia in several other tissues also expressed very high levels of PETA-3. Such structures included bile ducts, terminal bronchioles, and pancreatic intralobular ducts. CD9, CD63, and ␤1 integrins showed similar localization in these tissues, although CD9 was not detected on pancreatic ducts. Interestingly, staining of bile duct and pancreatic duct epithelia for these antigens was diffuse, suggesting cytoplasmic localization. However, studies on biopsy material would be required to eliminate postmortem degeneration as a cause for this appearance.
Previous studies with MAb 14A2.H1 have characterized the expression of PETA-3 in hemopoietic cells within bone marrow and peripheral blood. These studies showed expression to be restricted to megakaryocytes and platelets (Ashman et al. 1991; von dem Borne 1989) . In tonsil sections, PETA-3 expression was reported on the squamous epithelium and blood vessels (Ashman et al. 1991) . The results of the present study are in general agreement with these previous findings on hemopoietic cells and tonsil. However, some immature cell types within the BMMNC population and follicular dendritic cells within tonsil follicles also showed PETA-3 expression. The most likely cause of these differences may be the use of MAb 14A2.H1 in the earlier study. 14A2.H1 displays weaker staining of the PETA-3 antigen than MAb 11B1.G4, which was used in the present investigation. Furthermore, the recognition of PETA-3 by 14A2.H1 has been demonstrated to be fixation-and glycosylation-sensitive. In the present study methanol rather than buffered formol acetone was used as fixative. Lymphocytes in blood and in organized secondary lymphoid tissues (spleen and tonsil) did not express PETA-3 or the other tetraspans investigated. An interesting exception was the population of IELs in the small intestine. These cells, which appear to be extrathymically-derived T-cells, express several unique antigens, including the ␣E␤7 integrin (Yuan et al. 1991 ). This appears to be the first report describing expression of tetraspan molecules CD9 and CD63 by IELs, and their restriction to this subset of lymphocytes may be related to the specialized microenvironment occupied by these cells.
The tissue distribution of CD9, as described in the present study, is in general agreement with previous work (Rossler et al. 1992; Bouchiex et al. 1985; Jones et al. 1982) , with the exception of skeletal and cardiac muscle. Skeletal muscle had been reported as being negative and cardiac muscle positive by anti-CD9 MAb ALB 6 or DU-ALL-1. The opposite was observed in this study. Such discrepancies may arise because different anti-CD9 MAbs may not necessarily be equivalent in their recognition of CD9. For example, the glycosylation state of CD9 in different cell types may vary, thus modifying antigen recognition by certain antibodies.
In summary, this study has shown that PETA-3 colocalizes with ␤1 integrins and the other tetraspans CD9 and CD63 in particular tissues. However, it is important to note that distinct localization of several antigens investigated occurred in several tissues. This may indicate that tetraspan molecules share common functions in a number of tissues but that they may also have specific functions in some cell types. This is exemplified by PETA-3 in cardiac muscle, CD9 in tissue components of the brain and medullary rays of the kidney, CD63 in pancreatic ancinar cells, and the apical localization of CD63 in enterocytes. Furthermore, co-expression of these antigens by a given cell type may not always imply that they form complexes. For example, compartmentalization of CD63 within intracellular granules in enterocytes would prevent its association with surface antigens. Whether the complexes formed by tetraspans and integrins are constitutive or inducible remains to be investigated. However, the colocalization of these antigens in normal tissues provides a basis for such interactions to occur.
